Antibiotic Combination Therapy with Bramitob in Patients with Cystic Fibrosis with Chronic Pseudomonas Infection of the Lung

Trial Profile

Antibiotic Combination Therapy with Bramitob in Patients with Cystic Fibrosis with Chronic Pseudomonas Infection of the Lung

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Sep 2016

At a glance

  • Drugs Tobramycin (Primary) ; Colistin
  • Indications Cystic fibrosis; Pseudomonal infections
  • Focus Adverse reactions
  • Acronyms KOBRA
  • Most Recent Events

    • 02 Apr 2013 Status changed from recruiting to completed as reported by German Clinical Trials Register record.
    • 17 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top